These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 19080627

  • 1. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ, Zhang L, Ouyang YS.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2474-7. PubMed ID: 19080627
    [Abstract] [Full Text] [Related]

  • 2. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
    Xiao YP, Xiao EH, Luo JG, Bian DJ, Li MQ, He Z, Shang QL, Liang B.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 16; 30(12):914-6. PubMed ID: 19173992
    [Abstract] [Full Text] [Related]

  • 3. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr 16; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 4. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.
    J Vasc Interv Radiol; 2006 Mar 16; 17(3):505-12. PubMed ID: 16567675
    [Abstract] [Full Text] [Related]

  • 5. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R, Wang JH, Zhou KR, Yan FH, Yan ZP, Shen JZ, Tan YS, Cai Y.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct 16; 13(10):754-8. PubMed ID: 16248948
    [Abstract] [Full Text] [Related]

  • 6. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec 16; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study of transcatheter arterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma by magnetic resonance imaging and functional diffusion-weighted imaging].
    Liu YB, Liang CH, Wang QS, Xie SF, Yu YX, Zhang ZL, Liu ZY.
    Zhonghua Yi Xue Za Zhi; 2010 Nov 09; 90(41):2922-6. PubMed ID: 21211398
    [Abstract] [Full Text] [Related]

  • 8. Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver.
    Youn BJ, Chung JW, Son KR, Kim HC, Jae HJ, Lee JM, Song IC, Kim IO, Park JH.
    Acad Radiol; 2008 May 09; 15(5):593-600. PubMed ID: 18423316
    [Abstract] [Full Text] [Related]

  • 9. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
    Yu JS, Kim JH, Chung JJ, Kim KW.
    J Magn Reson Imaging; 2009 Jul 09; 30(1):153-60. PubMed ID: 19557734
    [Abstract] [Full Text] [Related]

  • 10. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
    Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B.
    Eur J Radiol; 2013 Apr 09; 82(4):577-82. PubMed ID: 23246330
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H, Harman M, Cinar C, Bozkaya H, Parildar M, Elmas N.
    J Vasc Interv Radiol; 2012 Feb 09; 23(2):241-7. PubMed ID: 22019180
    [Abstract] [Full Text] [Related]

  • 12. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
    Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF.
    J Comput Assist Tomogr; 2008 Feb 09; 32(3):347-52. PubMed ID: 18520535
    [Abstract] [Full Text] [Related]

  • 13. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.
    Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B.
    AJR Am J Roentgenol; 2009 Oct 09; 193(4):1044-52. PubMed ID: 19770328
    [Abstract] [Full Text] [Related]

  • 14. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization.
    Dong S, Ye XD, Yuan Z, Xu LC, Xiao XS.
    Eur J Radiol; 2012 Mar 09; 81(3):472-7. PubMed ID: 21296517
    [Abstract] [Full Text] [Related]

  • 15. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.
    J Vasc Interv Radiol; 2007 Aug 09; 18(8):957-63. PubMed ID: 17675611
    [Abstract] [Full Text] [Related]

  • 16. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M, Haas S, Loehr M, Elshwi M, Singer MV, Brade J, Schoenberg SO, Diehl SJ.
    Onkologie; 2010 Aug 09; 33(1-2):31-7. PubMed ID: 20164659
    [Abstract] [Full Text] [Related]

  • 17. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 18. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
    Rhee TK, Naik NK, Deng J, Atassi B, Mulcahy MF, Kulik LM, Ryu RK, Miller FH, Larson AC, Salem R, Omary RA.
    J Vasc Interv Radiol; 2008 Aug 24; 19(8):1180-6. PubMed ID: 18656011
    [Abstract] [Full Text] [Related]

  • 19. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
    Nishihara Y, Aishima S, Kuroda Y, Iguchi T, Taguchi K, Asayama Y, Taketomi A, Kinukawa N, Honda H, Tsuneyoshi M.
    J Gastroenterol Hepatol; 2008 Dec 24; 23(12):1860-8. PubMed ID: 18823434
    [Abstract] [Full Text] [Related]

  • 20. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA.
    Murakami T, Nakamura H, Hori S, Tomoda K, Mitani T, Nakanishi K, Hashimoto T, Tsuda K, Kozuka T, Monden M.
    Acta Radiol; 1993 Jul 24; 34(4):399-403. PubMed ID: 8391291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.